Bicocca Open Archive

Logo unimib boa
FACCHETTI, RITA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.891
AS - Asia 11.999
EU - Europa 8.949
SA - Sud America 1.793
Continente sconosciuto - Info sul continente non disponibili 895
AF - Africa 290
OC - Oceania 17
Totale 44.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.584
SG - Singapore 4.751
CN - Cina 2.396
IT - Italia 1.999
HK - Hong Kong 1.493
DE - Germania 1.482
RU - Federazione Russa 1.451
VN - Vietnam 1.424
BR - Brasile 1.350
CA - Canada 1.112
SE - Svezia 985
IE - Irlanda 815
UA - Ucraina 532
GB - Regno Unito 508
FR - Francia 390
BD - Bangladesh 387
IN - India 351
FI - Finlandia 213
KR - Corea 185
AR - Argentina 143
IQ - Iraq 139
TR - Turchia 132
ID - Indonesia 102
PK - Pakistan 95
ZA - Sudafrica 88
PH - Filippine 86
MX - Messico 85
ES - Italia 84
JP - Giappone 82
PL - Polonia 76
EC - Ecuador 74
NL - Olanda 72
CO - Colombia 68
DK - Danimarca 63
UZ - Uzbekistan 62
AT - Austria 58
SA - Arabia Saudita 56
VE - Venezuela 52
BE - Belgio 47
MY - Malesia 35
EG - Egitto 34
CZ - Repubblica Ceca 32
CL - Cile 31
MA - Marocco 29
AE - Emirati Arabi Uniti 25
PY - Paraguay 25
ET - Etiopia 24
KE - Kenya 23
TN - Tunisia 22
PE - Perù 21
JO - Giordania 20
JM - Giamaica 19
CR - Costa Rica 18
IR - Iran 18
RO - Romania 17
KZ - Kazakistan 16
LT - Lituania 16
AU - Australia 15
OM - Oman 15
TW - Taiwan 15
UY - Uruguay 15
AZ - Azerbaigian 13
CH - Svizzera 13
HN - Honduras 13
LB - Libano 13
NP - Nepal 13
TH - Thailandia 13
DZ - Algeria 12
PT - Portogallo 12
EU - Europa 11
GR - Grecia 11
SN - Senegal 11
BO - Bolivia 10
TT - Trinidad e Tobago 10
AL - Albania 9
BG - Bulgaria 9
GT - Guatemala 9
IL - Israele 9
GE - Georgia 8
PA - Panama 8
PS - Palestinian Territory 8
BH - Bahrain 7
LK - Sri Lanka 7
SK - Slovacchia (Repubblica Slovacca) 7
BB - Barbados 6
CM - Camerun 6
DO - Repubblica Dominicana 6
HR - Croazia 6
MK - Macedonia 6
NG - Nigeria 6
BY - Bielorussia 5
CI - Costa d'Avorio 5
HU - Ungheria 5
NI - Nicaragua 5
XK - ???statistics.table.value.countryCode.XK??? 5
GY - Guiana 4
KG - Kirghizistan 4
KH - Cambogia 4
LV - Lettonia 4
NO - Norvegia 4
Totale 43.874
Salva come PNG Salva come JPEG
Città #
Singapore 2.521
Ann Arbor 2.133
Ashburn 1.959
Hong Kong 1.459
San Jose 1.421
Woodbridge 1.163
Fairfield 945
Houston 942
Toronto 824
Dublin 780
Chandler 756
Milan 707
Frankfurt am Main 657
New York 606
Wilmington 598
Jacksonville 556
Dearborn 470
Seattle 448
Ho Chi Minh City 428
Santa Clara 419
Dallas 404
Beijing 402
Cambridge 364
Council Bluffs 348
Los Angeles 338
Chicago 337
Hefei 329
Hanoi 319
Princeton 284
The Dalles 222
Rome 188
Boardman 174
Seoul 174
Lauterbourg 172
Nanjing 157
Moscow 152
Shanghai 146
São Paulo 131
Buffalo 130
Lawrence 130
Munich 129
Altamura 127
Orem 100
San Diego 98
Lachine 94
Columbus 79
Helsinki 74
Atlanta 72
Phoenix 72
Da Nang 69
Baghdad 60
Rio de Janeiro 60
London 59
Montreal 59
Nanchang 59
Dong Ket 58
Tokyo 58
Brooklyn 57
Guangzhou 57
Warsaw 56
Haiphong 54
Chennai 52
Denver 51
Ottawa 51
Andover 49
Falls Church 48
Tashkent 48
Figino 45
Mumbai 44
Hebei 43
Shenyang 42
Jakarta 41
Fremont 40
Tianjin 40
Brussels 39
Lissone 39
Nürnberg 39
Dhaka 38
Changsha 36
Johannesburg 36
Nuremberg 35
Salt Lake City 34
Turku 34
Vienna 34
Belo Horizonte 33
Pune 32
Turin 32
Manchester 31
Stockholm 31
Jinan 30
Norwalk 30
Quito 30
Poplar 28
San Francisco 28
Zhengzhou 27
Philadelphia 26
Brno 25
Mexico City 25
Boston 24
Kunming 24
Totale 27.658
Salva come PNG Salva come JPEG
Nome #
Relationship between arterial distensibility and coronary atherosclerosis in angina patients 506
Self-reported prevalence of sleep disorders among medical and nursing students 494
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 440
Early alterations in left ventricular diastolic function in normotensive diabetic patients 396
Persistence of arterial functional abnormalities after successful coronary revascularization 391
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 390
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 372
Differing associations for sport versus occupational physical activity and cardiovascular risk 370
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 362
Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? 358
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 347
Risk behaviors among Italian healthcare students: a cross-sectional study for health promotion of future healthcare workers 340
Biological consequences of stress: Conflicting findings on the association between job strain and blood pressure 336
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 336
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 336
8c.04: Possible role of arterial function in cancer treatment targeting vascular endothelial growth factor receptor oncologic response 333
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 333
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 333
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 332
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 328
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 324
The Pamela study: main findings and perspectives 319
Effects of Cancer Therapy Targeting Vascular Endothelial Growth Factor Receptor on Central Blood Pressure and Cardiovascular System 319
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 316
Multiparametric carotid and cardiac ultrasound compared with clinical risk scores for the prediction of angiographic coronary artery disease: A multicenter prospective study 315
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 313
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 311
Evaluation of How Gene-Job Strain Interaction Affects Blood Pressure in the PAMELA Study 306
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 299
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 297
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 295
Ultrasound carotid intima-media thickness, carotid plaque and cardiac calcium incrementally add to the Framingham Risk Score for the prediction of angiographic coronary artery disease : a multicenter prospective study 294
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 289
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 288
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 287
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 284
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 284
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 282
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 279
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 279
Differential incremental value of ultrasound carotid intima-media thickness, carotid plaque, and cardiac calcium to predict angiographic coronary artery disease across Framingham risk score strata in the APRES multicentre study 279
New-onset left atrial enlargement in a general population 278
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 277
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 276
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 274
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 274
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 273
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 272
Relationship between vascular damage and left ventricular concentric geometry in patients undergoing coronary angiography: a multicenter prospective study 272
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 270
Biological and social values of metabolic syndrome in predicting cardiovascular disease 269
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 269
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 266
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 261
Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus 259
New onset left atrial dilatation in the general population: A quarter-century follow-up 258
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 258
Annexin A5 in treated hypertensive patients and its association with target organ damage 257
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 256
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 256
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 254
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 253
HIV and metabolic syndrome - A comparison with the general population 252
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 250
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 249
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 247
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 247
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 247
Ultrasonographic backscatter of the carotid artery wall in patients with HIV infection: a pilot study 246
Metabolic syndrome in human immunodeficiency virus-positive subjects: prevalence, phenotype, and related alterations in arterial structure and function 245
Should white-coat hypertension in diabetes be treated? Pro 244
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 244
Incident Left Ventricular Hypertrophy in Masked Hypertension 244
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 242
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 241
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 240
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 239
Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients 238
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study 238
The Pamela Study: Old and New Findings 237
Predictive value of different indices of blood pressure variability on 237
Long-term risk of sustained hypertension in white-coat or masked hypertension 235
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 235
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 233
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 233
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 230
THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS 230
Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the PAMELA study 229
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 228
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 228
Home and ambulatory blood pressure in resistant hypertension 226
High-normal blood pressure and abnormal left ventricular geometric patterns: A meta-analysis 226
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting 226
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 224
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 222
Structural and functional alterations of large arteries in HIV patients and their relationships with metabolic syndrome. 222
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 221
Cystatin C and its association with carotid plaqua and intima media thickness in subjects without known cardiovascular and kidney diseases 221
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 220
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 219
Totale 28.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.575 0 0 198 169 138 146 91 90 99 156 137 351
2022/20233.192 388 955 276 284 175 502 61 201 187 30 91 42
2023/20242.685 75 68 115 154 352 711 482 104 224 59 47 294
2024/20257.114 344 791 303 290 563 183 358 351 609 965 939 1.418
2025/202617.292 1.794 1.010 1.259 1.768 1.884 883 2.459 701 1.320 1.548 1.331 1.335
2026/20271.577 484 723 370 0 0 0 0 0 0 0 0 0
Totale 44.834